
FDA adviser resigns over approval of new Alzheimer's drug
CNN
A member of an FDA advisory committee said Wednesday he had resigned over the agency's approval of a new Alzheimer's drug.
The FDA approved aducanumab, to be sold under the brand name Aduhelm, this week over the objections of its advisory Peripheral and Central Nervous System Drugs Advisory Committee. Mayo Clinic neurologist Dr. David Knopman told CNN Wednesday he had resigned from the committee in protest.More Related News

The Trump administration has quietly fired multiple members of the “privacy team” and other officials from the office that oversees the hiring of federal workers, a move that limits outside access to government records related to the security clearances granted to Elon Musk and his associates, according to multiple sources familiar with the matter.